reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 121085 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121085.

121085.  (a) Confidential research records shall be protected in the course of conducting financial audits or program evaluations, and audit personnel shall not directly or indirectly identify any individual research subject in any report of a financial audit or program evaluation. To the extent it is necessary for audit personnel to know the identity of individual research subjects, authorized disclosure of confidential research records shall be made on a case-by-case basis, and every prudent effort shall be exercised to safeguard the confidentiality of these research records in accordance with this chapter. Information disclosed for audit or evaluation purposes should be used only for audit and evaluation purposes and may not be redisclosed or used in any other way.(b) Nothing in this section imposes liability or criminal sanction for disclosure of confidential research records in accordance with any reporting requirement for a case of HIV, including AIDS, by the department or the Centers for Disease Control and Prevention under the United States Public Health Services.(Amended by Stats. 2006, Ch. 20, Sec. 10. Effective April 17, 2006.)
CA Health & Safety Code § 121090 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121090.

121090.  Notwithstanding Section 121080, whether or not the research subject, with respect to whom any confidential research record is maintained, gives prior written consent, the content of the confidential research record may be disclosed in any of the following situations:(a)  To medical personnel to the extent it is necessary to meet a bona fide medical emergency of a research subject. (b)  To the department to the extent necessary for the conduct of a special investigation pursuant to Section 100325, in which case the confidentiality provisions of Chapter 8 (commencing with Section 121025) shall apply. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121095 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121095.

121095.  The content of any confidential research record shall be disclosed to the research subject, the legal representative of the research subject if the research subject is a minor, or the personal representative of a deceased research subject to whom the record pertains, thirty (30) days after written request therefor by the research subject, the legal representative or the personal representative.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121100 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121100.

121100.  (a)  No confidential research record may be compelled to be produced in any state, county, city or other proceeding in order to initiate or substantiate any criminal charge or charges against a research subject, or to conduct an investigation of a research subject, unless a court finds there is reasonable likelihood that the records in question will disclose material information or evidence of substantial value in connection with the criminal charge or charges or investigation, and there is no other practicable way of obtaining the information or evidence. In addition, no confidential research record shall be disclosed, discoverable, or compelled to be produced in order to initiate or substantiate any criminal charge or charges against a research subject until after a showing of good cause. In assessing good cause, the court shall weigh the public interest and need for disclosure against the injury to the research subject and the harm to the research being undertaken. Upon the granting of an order to produce, the court, in determining the extent to which disclosure of all or any part of a confidential research record is necessary, shall impose appropriate safeguards against unauthorized disclosure, that shall include, but not necessarily be limited to, the individuals or bodies that may have access to the data, the purposes for which the data shall be used, prohibitions on further disclosure and protection of the identities of other research subjects.(b)  No confidential research record may be compelled to be produced in any state, county, city or other civil proceeding, except as expressly provided in this chapter. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121105 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121105.

121105.  Prior to participation of an individual in a research study relating to HIV or AIDS, both of the following requirements shall be met:(a) The informed consent of each research subject shall be obtained in the method and manner required by Section 46.116, (a) and (b), of Part 46 of Title 45 of the Code of Federal Regulations and be documented in accordance with Section 46.117 of that part.(b) Each research subject shall be provided with an explanation in writing, in language understandable to the research subject, of the rights and responsibilities of researchers and research subjects under this chapter.(Amended by Stats. 2006, Ch. 20, Sec. 11. Effective April 17, 2006.)
CA Health & Safety Code § 121110 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121110.

121110.  (a) Any person who negligently discloses the content of any confidential research record, as defined in subdivision (c) of Section 121125, to any third party, except pursuant to this chapter, shall be assessed a civil penalty in an amount not to exceed two thousand five hundred dollars ($2,500), plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.(b) Any person who willfully or maliciously discloses the content of any confidential research record, as defined in subdivision (c) of Section 121125, to any third party, except pursuant to this chapter, shall be assessed a civil penalty in an amount not less than five thousand dollars ($5,000) and not more than ten thousand dollars ($10,000), plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.(c) Any person who willfully, maliciously, or negligently discloses the content of any confidential research record, as defined in subdivision (c) of Section 121125, to a third party, except pursuant to this chapter, that results in economic, bodily, or psychological harm to the research subject, is guilty of a misdemeanor, punishable by imprisonment in the county jail for a period not to exceed one year, or a fine of not to exceed twenty-five thousand dollars ($25,000), or both.(d) Any person who commits any act described in subdivision (a) or (b) shall be liable to the subject for all actual damages for economic, bodily, or psychological harm that is a proximate result of the act.(e) Any person who negligently or willfully violates Section 121105 is guilty of an infraction punishable by a fine of twenty-five dollars ($25).(f) Each violation of this chapter is a separate and actionable offense.(g) Nothing in this section limits or expands the right of an injured research subject to recover damages under any other applicable law.(Amended by Stats. 2006, Ch. 20, Sec. 12. Effective April 17, 2006.)
CA Health & Safety Code § 121115 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121115.

121115.  In the event that the participation of an individual in a research study is disclosed, the information shall not be used to determine the employability or insurability of the research subject.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121120 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121120.

121120.  Nothing in this chapter shall preclude disclosure of information in order to further research efforts, including, but not limited to, the publication, dissemination, or sharing of raw data, statistics, or case studies, so long as no confidential research records concerning any research subject are disclosed.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121125 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 10 - Acquired Immune Deficiency Syndrome (AIDS) Research Confidentiality Act|Section 121125.

121125.  For purposes of this chapter:(a) “AIDS” means acquired immunodeficiency syndrome.(b) “Disclosed” means to disclose, release, transfer, disseminate, or otherwise communicate all or any part of any confidential research record orally, in writing, or by electronic means to any person or entity, or to provide the means for obtaining the records.(c) “Confidential research record or records” means any data or information in a personally identifying form, including name, social security number, address, employer, or other information that could, directly or indirectly, in part or in sum, lead to the identification of the individual research subject, developed or acquired by any person in the course of conducting research or a research study relating to HIV or AIDS.(d) “HIV” means human immunodeficiency virus.(Amended by Stats. 2006, Ch. 20, Sec. 13. Effective April 17, 2006.)
CA Health & Safety Code § 121150 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121150.

121150.  The Legislature hereby finds and declares that the department, working with the California AIDS Leadership Committee, has developed a draft state AIDS plan for comprehensive, coordinated government action against AIDS and HIV infection. It is the intention of the Legislature to implement those recommendations pertaining to infectious-disease screening of blood and other body parts and fluids, and to notifying donors of the results of those screening tests.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121155 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121155.

121155.  (a)  There is hereby created in the state department an AIDS Advisory Committee. The membership of the committee shall be composed of eight members who have knowledge or expertise in the area of public health or AIDS research, or have been educated in the areas for which the grants are to be directed by the committee. These members shall be appointed by the following: (1)  Two by the Speaker of the Assembly. (2)  Two by the Senate Rules Committee. (3)  Four by the Governor. (b)  In addition to the membership prescribed by subdivision (a), the following persons shall be ex officio members: (1)  The Director of Health Services or a designee shall be a voting member. (2)  The Director of Mental Health, or a designee, a designee, requested to be appointed by the President of the University of California, with knowledge, experience, and responsibility for the university-wide allocation of AIDS research grants, shall be nonvoting members. (c)  The committee shall be abolished effective July 1, 1990, unless extended by subsequent legislative action. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121160 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121160.

121160.  The members of the AIDS Advisory Committee shall serve at the pleasure of the appointing powers. The members shall serve without compensation, but shall be reimbursed for necessary and travel expenses incurred in the performance of the duties of the committee.The committee shall advise and assist the state in addressing the public health issues associated with Acquired Immune Deficiency Syndrome, and shall work with the department in statewide efforts to promote primary prevention, public education, and the advancement of knowledge regarding Acquired Immune Deficiency Syndrome.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121165 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121165.

121165.  The committee may establish rules or criteria for grants under this chapter as it deems necessary. Pursuant to the rules or criteria, the committee may review and recommend approval by the director of grant applications and monitor programs receiving grants under this chapter.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121170 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121170.

121170.  The director may award grants from any funds that may be made available for the purposes of this chapter to individuals, organizations, or facilities for activities that may include, but need not be limited to, any of the following:(a)  Education regarding primary prevention for high risk groups. (b)  Public education to reduce panic and lessen unnecessary anxiety about AIDS among California residents. (c)  Interdisciplinary or educational workshops to facilitate the interchange of knowledge among investigators regarding AIDS and related disorders. (d)  Research grants that would assist the state with the educational efforts outlined in subdivisions (a) and (b). (e)  Grants to provide seed money for larger grants funded by the federal government or other sources. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121175 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121175.

121175.  The department may do all of the following:(a)  Accept any federal funds provided for any of the purposes of this chapter. (b)  Accept any gift, donation, bequest, or grant of funds from a private or public agency for any of the purposes of this chapter. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121180 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 11 - Acquired Immune Deficiency Syndrome (AIDS) Research and Workshop Grants|Section 121180.

121180.  Not more than 10 percent of any money appropriated for purposes of this chapter shall be utilized for the administration of this chapter.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121200 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 12 - Acquired Immune Deficiency Syndrome (AIDS) Vaccine Research and Development Grant Program|Section 121200.

121200.  The Legislature finds and declares all of the following:(a)  Over the past five years AIDS has reached an epidemic stage and is estimated to affect 30,000 Californians by 1990. (b)  The estimated cost of medical care alone for the 4,000 AIDS cases that have occurred to date in California totals approximately two hundred fifty million dollars ($250,000,000). By the end of 1990, medical care is projected to approach three billion five hundred million dollars ($3,500,000,000) and the total public health and medical care expenditures are expected to exceed five billion dollars ($5,000,000,000). (c)  There is no cure for the AIDS virus. The long-term solution to the elimination of AIDS lies in conducting vaccine research. (d)  Much research has already been completed by the private sector and should be utilized to the maximum extent possible, including supplementing with public funds. (e)  Profitmaking corporations are (1) not eligible for most of the existing public funding sources as are institutions of higher learning and nonprofit corporations; (2) when eligible, the public funding amounts are not adequate to conduct research; and (3) private grants are only available to nonprofit corporations. (f)  Moreover, private research companies, already having established vaccine development and manufacturing capabilities, are uniquely situated to maximize available resources and to utilize both management and research staff, equipment, and technical innovations to their greatest efficiency towards the specific goal of developing and manufacturing an AIDS vaccine at the earliest possible time. (g)  Exclusion of private corporations from public funding to develop an approved vaccine will likely result in (1) a delay in the development of a vaccine to prevent AIDS; (2) continued spread of AIDS to the general population; and (3) continued increases in private and public funds to provide care to AIDS victims. (h)  It is appropriate to mandate that a grant made to a private entity to develop an AIDS vaccine, once the vaccine has been approved by the FDA for use by the general population, should be reimbursed to the state from the sale of the vaccine. (Amended by Stats. 1997, Ch. 294, Sec. 18. Effective August 18, 1997.)
CA Health & Safety Code § 121225 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 12 - Acquired Immune Deficiency Syndrome (AIDS) Vaccine Research and Development Grant Program|Section 121225.

121225.  If a California manufacturer that is a grant recipient sells, delivers, or distributes an AIDS vaccine that has received FDA approval for use by the general population and that was developed in whole or in part using a grant awarded pursuant to this chapter, the State of California shall be reimbursed for the grant as provided in this section.Until the total amount of the grant is repaid, repayments in the amount of one dollar ($1) per dose from the sale of the AIDS vaccine shall be deposited by the grant recipient into the General Fund. Upon payment in full of the grant amount into the General Fund, a royalty on the sale of the vaccine from the grant recipient shall be deposited into the General Fund. The percentage amount of the royalty shall be negotiated at the time of the grant award.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121265 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13 - Acquired Immune Deficiency Syndrome (AIDS) Immunization|Section 121265.

121265.  “State,” as used in this chapter, has the same meaning as set forth in Section 900.6 of the Government Code.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 121280 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 13 - Acquired Immune Deficiency Syndrome (AIDS) Immunization|Section 121280.

121280.  (a)  In enacting this section the Legislature finds and declares: (1)  It is in the interest of the people of California to develop a vaccine that will prevent the infection of HIV, the agent that causes AIDS. (2)  In order to develop that vaccine, a prototype vaccine must be first given to HIV-negative people to determine the following: (A)  The vaccine’s toxicity. (B)  The vaccine’s efficacy. (C)  The human immune response to the vaccine. (3)  These studies are currently impossible because vaccine manufacturers fear that, by inoculating HIV-negative individuals with an experimental vaccine, they will elicit a positive immune response as measured by an enzyme linked immunosorbent assay (ELISA), western blot or other federal Food and Drug Administration approved in vitro diagnostic test, thereby placing vaccine volunteers at risk for denial of health or life insurance by insurance carriers as a consequence of their participation. (4)  Insurers need a reliable mechanism by which they can verify the insurability of a vaccine trial participant. (b)  No health care service plan, disability insurer, nonprofit hospital service plan, self-insured employee welfare benefit plan, or life insurer may withhold any settlement or coverage of an individual solely because of his or her participation in an AIDS/HIV vaccine clinical trial studied under an investigational new drug application effective pursuant to Section 312 of Title 21 of the Code of Federal Regulations, or Section 111595. (c)  The sponsor of any such trial shall make a confidential certificate with all the necessary particulars, which shall be determined by the department, for each enrollee and then submit it to the department, which shall endorse it and return it to the vaccine recipient. A copy of this confidential certificate shall be kept on file indefinitely by both the study sponsor and the department. (d)  Release of a confidential certificate shall be by written authorization of the enrollee named in the certificate. If the enrollee is unable to provide the written authorization, a person designated in the certificate by the enrollee may provide the written authorization. The written authorization shall include the name of the person or entity to whom the disclosure would be made. Disclosure as used in this section means to release, transfer, disseminate or otherwise communicate all or part of any confidential certificate orally, in writing, or by electronic means to any person or entity.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)